COMP <GO>
LFST vs OPCH // EV/EBITDA & P/E VALUATION
LifeStance Health Group Inc. (NASDAQ) VS. Option Care Health Inc. (NASDAQ) • 15-METRIC TALLY: LFST 4
— OPCH 6
▲ EV/EBITDA & P/E VALUATION LEADER: OPCH
LAST: $13.26 (-1.04%) • MKT CAP: $5.12B
valuation
95.3x
LAST: $31.69 (-0.44%) • MKT CAP: $4.77B
valuation
15.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LFST VS. OPCH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LFST | OPCH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 19.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.20% | 11.90% | -10.70 | OPCH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 95.3x | 15.3x | +80.00 | OPCH | /valuation <GO> |
| Free Cash Flow Yield | 2.11% | 4.55% | -2.44 | OPCH | /fcf-yield <GO> |
| Operating Margin | 1.70% | 6.00% | -4.30 | OPCH | /operating-margins <GO> |
| Net Profit Margin | 0.70% | 3.70% | -3.00 | OPCH | /net-margins <GO> |
| Revenue Growth (YoY) | 13.90% | 13.00% | +0.90 | LFST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.84 | 3.81 | +1.03 | LFST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | LFST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.2 | 83.8 | -21.60 | OPCH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.10 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 19.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.12B | $4.77B | $353.2M | LFST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LFST REV | OPCH REV | LFST GROSS % | OPCH GROSS % | LFST FCF | OPCH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.42B | $5.65B | — | 19.3% | $110.0M | $217.1M |
| FY 2024 | $1.25B | $5.00B | — | 20.3% | $85.7M | $287.8M |
| FY 2023 | $1.06B | $4.30B | — | — | -$16.9M | $177.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LFST // BETA —
OPCH // BETA 1.10